Kimberly Linthicum is named as a lobbyist on federal disclosure filings for 51 clients through Todd Strategy Group and 1 other registrant. The most recent filing naming them posted in October 2026. Issues reported include Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code and Pharmacy.
Filers must list covered executive or legislative branch positions held. As filed:
| Client | Registrant | Latest | Issues |
|---|---|---|---|
| CAREDX, INC. | CAREDX, INC. | Q3 2026 | Medicare/Medicaid, Health Issues |
| AMERICAN POLICY VENTURES ACTION | TODD STRATEGY GROUP | Q3 2025 | Economics/Economic Development, Taxation/Internal Revenue Code |
| NOVARTIS, INC. | TODD STRATEGY GROUP | Q2 2025 | Medicare/Medicaid, Health Issues |
| FLEXCARE | TODD STRATEGY GROUP | Q1 2025 | Health Issues |
| THE COALITION FOR 21ST CENTURY MEDICINE | TODD STRATEGY GROUP | Q1 2025 | Medicare/Medicaid |
| U.S. CHAMBER OF COMMERCE GLOBAL INNOVATION POLICY CENTER | TODD STRATEGY GROUP | Q1 2025 | Copyright/Patent/Trademark |
| TRUIST FINANCIAL CORPORATION | TODD STRATEGY GROUP | Q1 2025 | Banking |
| TAKEDA PHARMACEUTICALS AMERICA, INC. | TODD STRATEGY GROUP | Q1 2025 | Medicare/Medicaid, Health Issues |
| SOUTHWEST TRANSPLANT ALLIANCE | TODD STRATEGY GROUP | Q1 2025 | Health Issues |
| SIEMENS HEALTHINEERS | TODD STRATEGY GROUP | Q1 2025 | Medicare/Medicaid |
| SIDECAR HEALTH | TODD STRATEGY GROUP | Q1 2025 | Health Issues |
| PUERTO RICO DEPARTMENT OF HEALTH | TODD STRATEGY GROUP | Q1 2025 | Medicare/Medicaid, Budget/Appropriations |
| PMI US CORPORATE SERVICES INC. | TODD STRATEGY GROUP | Q1 2025 | Tobacco, Government Issues, Budget/Appropriations |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | TODD STRATEGY GROUP | Q1 2025 | Medicare/Medicaid, Pharmacy |
| OTSUKA AMERICA PHARMACEUTICAL, INC. | TODD STRATEGY GROUP | Q1 2025 | Health Issues |
| OSRX PHARMACEUTICALS | TODD STRATEGY GROUP | Q1 2025 | Health Issues |
| THE ORTHOFORUM | TODD STRATEGY GROUP | Q1 2025 | Medicare/Medicaid |
| NOVO NORDISK INC. | TODD STRATEGY GROUP | Q1 2025 | Health Issues |
| NETLIST, INC. | TODD STRATEGY GROUP | Q1 2025 | Copyright/Patent/Trademark |
| MYRIAD GENETICS, INC. | TODD STRATEGY GROUP | Q1 2025 | Medicare/Medicaid |
| MUTUAL OF OMAHA | TODD STRATEGY GROUP | Q1 2025 | Insurance |
| MERCK & CO., INC. | TODD STRATEGY GROUP | Q1 2025 | Medicare/Medicaid, Health Issues |
| MEDICAL COUNTERMEASURES COALITION | TODD STRATEGY GROUP | Q1 2025 | Health Issues |
| MED CLAIMS COMPLIANCE CORPORATION | TODD STRATEGY GROUP | Q1 2025 | Medicare/Medicaid |
| MCKESSON CORPORATION | TODD STRATEGY GROUP | Q1 2025 | Medicare/Medicaid |
| KALDEROS, INC. | TODD STRATEGY GROUP | Q1 2025 | Health Issues |
| JOHNSON & JOHNSON SERVICES, INC. | TODD STRATEGY GROUP | Q1 2025 | Health Issues |
| ILLUMINA, INC. | TODD STRATEGY GROUP | Q1 2025 | Health Issues |
| HOSPICE COMPASSUS | TODD STRATEGY GROUP | Q1 2025 | Medicare/Medicaid, Health Issues |
| GILEAD SCIENCES, INC. | TODD STRATEGY GROUP | Q1 2025 | Health Issues |
| GENMAB | TODD STRATEGY GROUP | Q1 2025 | Medicare/Medicaid, Health Issues |
| GENENTECH, INC. | TODD STRATEGY GROUP | Q1 2025 | Medicare/Medicaid, Pharmacy |
| FOX CORPORATION | TODD STRATEGY GROUP | Q1 2025 | Telecommunications, Communications/Broadcasting/Radio/TV, Taxation/Internal Revenue Code |
| FERRING PHARMACEUTICALS INC. | TODD STRATEGY GROUP | Q1 2025 | Health Issues |
| EXELIXIS, INC. | TODD STRATEGY GROUP | Q1 2025 | Medicare/Medicaid, Health Issues, Copyright/Patent/Trademark |
| EMD SERONO INC. | TODD STRATEGY GROUP | Q1 2025 | Pharmacy, Health Issues |
| ELI LILLY AND COMPANY | TODD STRATEGY GROUP | Q1 2025 | Medicare/Medicaid, Health Issues |
| DH DIAGNOSTICS LLC | TODD STRATEGY GROUP | Q1 2025 | Health Issues |
| PERIMETER SYSTEMS, INC. | TODD STRATEGY GROUP | Q1 2025 | Health Issues |
| BRISTOL-MYERS SQUIBB COMPANY | TODD STRATEGY GROUP | Q1 2025 | Medicare/Medicaid, Health Issues |
| BIOGEN, INC. | TODD STRATEGY GROUP | Q1 2025 | Medicare/Medicaid, Health Issues |
| BIODESIX, INC. | TODD STRATEGY GROUP | Q1 2025 | Medicare/Medicaid, Health Issues |
| BAYER CORPORATION | TODD STRATEGY GROUP | Q1 2025 | Health Issues |
| ASTELLAS PHARMA US, INC. | TODD STRATEGY GROUP | Q1 2025 | Pharmacy, Health Issues |
| APOLLO GLOBAL MANAGEMENT | TODD STRATEGY GROUP | Q1 2025 | Financial Institutions/Investments/Securities |
| AMERICAN SOCIETY OF NEPHROLOGY | TODD STRATEGY GROUP | Q1 2025 | Health Issues |
| AMERICAN MEDICAL ASSOCIATION | TODD STRATEGY GROUP | Q1 2025 | Medicare/Medicaid, Health Issues |
| AMERICAN COLLEGE OF RADIOLOGY | TODD STRATEGY GROUP | Q1 2025 | Medicare/Medicaid |
| ALNYLAM PHARMACEUTICALS, INC. | TODD STRATEGY GROUP | Q1 2025 | Medicare/Medicaid |
| ALKERMES, INC. | TODD STRATEGY GROUP | Q1 2025 | Health Issues |
| ALEXION PHARMACEUTICALS, INC. | TODD STRATEGY GROUP | Q1 2025 | Medicare/Medicaid, Health Issues |
| Year | Clients | Registrants |
|---|---|---|
| 2026 | 1 | 1 |
| 2025 | 51 | 2 |
| Year | Items | Total |
|---|---|---|
| 2026 | 1 | $1K |
Pay is not disclosed for individual lobbyists. Filings do not confirm that records with the same name are one person, so this page may combine people who share the name Kimberly Linthicum. See the Capitol Clarity rankings and method.